Navidea Biopharmaceuticals

$0.00 (0.00%) As of 8:41 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAVB and other ETFs, options, and stocks.

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO
Jed Andrew Latkin, MBA
Employees
18
Headquarters
Dublin, Ohio
Founded
1983

NAVB Key Statistics

Market cap
30.49M
Price-Earnings ratio
—
Dividend yield
—
Average volume
57.24K
High today
$1.01
Low today
$0.98
Open price
$1.01
Volume
58.37K
52 Week high
$3.15
52 Week low
$0.93

NAVB Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure